Home › Seizures › Washington › Seattle
Seizures clinical trials in Seattle, WA
4 studies for Seizures are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- University of Washington Regional Epilepsy Center, Seattle
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
RecruitingPhase 1
- Seattle Children's Hospital, Seattle
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
RecruitingPhase 3
- Seattle Children's Hospital, Seattle
Pediatric Dose Optimization for Seizures in Emergency Medical Services
RecruitingPhase 3
- University of Washington, Seattle
About Seizures
Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.
More about Seizures on MedlinePlus
Seizures trials in other cities
- New York City, NY13 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Houston, TX9 studies
- Birmingham, AL8 studies
- Miami, FL7 studies
- Boston, MA7 studies
- Cincinnati, OH6 studies
- San Francisco, CA6 studies
- Durham, NC6 studies
- Dallas, TX6 studies
- Chicago, IL5 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.